USPTO serial 79300538
FIH FIRST IN HUMAN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 21, 2021
- Examiner
- MAHMOUDI, MARIAM AZIZ
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with FIH FIRST IN HUMAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
KAINIC MEDICAL COMMUNICATIONS LIMITED
NZ
Other trademarks owned by KAINIC MEDICAL COMMUNICATIONS LIMITED
KAINIC MEDICAL COMMUNICATIONS LIMITED
NZ
Other trademarks owned by KAINIC MEDICAL COMMUNICATIONS LIMITED
KAINIC MEDICAL COMMUNICATIONS LIMITED
NZ
Other trademarks owned by KAINIC MEDICAL COMMUNICATIONS LIMITED
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Medical and pharmacological research services; scientific research services for medical purposes; providing information about medical and scientific research in the field of pharmaceuticals; technical writing; scientific analysis of technical data in the field of pharmaceuticals, medical diagnostics and medical devices; preparation of technical reports, namely, technical writing; scientific advisory and information services in the nature of preparation of reports relating to technical research in the field of pharmaceuticals, medical diagnostics and medical devices; scientific advisory and information services in the nature of preparation of reports relating to scientific research; scientific advisory and information services in the nature of preparation of scientific reports in the field of pharmaceuticals, medical diagnostics and medical devices; scientific advisory and information services in the nature of preparation of reports in the field of biotechnology; scientific advisory and information services in the nature of preparation of reports relating to clinical trials; providing information about the results of clinical trials for pharmaceuticals and medical devices; evaluation of chemical syntheses; evaluation of product development; pharmaceutical product evaluation; product quality evaluation; providing scientific research information and results from an online searchable database; consultancy relating to technical research and scientific analysis in the field of pharmaceuticals, medical diagnostics and medical devices | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by KAINIC MEDICAL COMMUNICATIONS LIMITED
- Other trademarks owned by KAINIC MEDICAL COMMUNICATIONS LIMITED
- Other trademarks owned by KAINIC MEDICAL COMMUNICATIONS LIMITED
- Other trademarks in Class 042
- Similar marks named FIH FIRST IN HUMAN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 4, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 11, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 11, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 21, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 21, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 6, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 6, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 16, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 1, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 1, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 1, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 1, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 1, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 21, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 21, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 21, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 21, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 21, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 11, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 19, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 19, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 15, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 14, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 8, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 2, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 29, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 24, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |